CGP 55845 hydrochloride
In vitro transcription of capped mRNA with modified nucleotides and Poly(A) tail
Tyramide Signal Amplification (TSA)
TSA (Tyramide Signal Amplification), used for signal amplification of ISH, IHC and IC etc.
Phos Binding Reagent Acrylamide
Separation of phosphorylated and non-phosphorylated proteins without phospho-specific antibody
Cell Counting Kit-8 (CCK-8)
A convenient and sensitive way for cell proliferation assay and cytotoxicity assay
SYBR Safe DNA Gel Stain
Safe and sensitive stain for visualization of DNA or RNA in agarose or acrylamide gels.
Protect the integrity of proteins from multiple proteases and phosphatases for different applications.
IC50: 5 nM
CGP 55845 is a potent, selective GABAB receptor antagonist that abolishes agonist binding (pKi = 8.35) and blocks GABA and glutamate release (pEC50 values are 8.08 and 7.85 respectively). CGP 55845 prevents GABAB responses to baclofen (IC50 = 130 nM in an isoproterenol assay) and increases the hypoglycemic response to glucose in vitro. [1,2]
Presynaptic GABAB receptors seem to regulate the release of several neurotransmitters. Baclofen, the GABAB agonist, that prevents the release of GABA itself via autoreceptors, was 10 times more potent in antagonizing the inhibitory effect of (-)-baclofen on the release of GABA and of somatostatin-like immunoreactivity (SRIF-LI) than of glutamate. However, CGP 35348 was about 70 times more potent in preventing the effect of baclofen on glutamate and SRIF-LI than on GABA release.
In vitro: Antagonist CGP 55845A of the GABAB receptor in the presence of CNQX and d(2)-2-amino-5-phosphonovaleric acid prevented the inhibitory postsynaptic potential-B and paired-pulse depression. .
This secretion was cadmium sensitive, potentiated by CGP 55845, and blocked by ketanserin. Taken together these data suggest that CB receptors act as direct glucosensors, and that processing of hypoglycaemia utilizes similar neurotransmitter and neuromodulatory mechanisms as hypoxia . The convulsant 4-aminopyridine (4-AP) and the GABAB receptor antagonist CGP 55845 both applied to adult guinea pig hippocampal to slices, resulting in eliciting giant GABA-mediated postsynaptic potentials (GPSPs) and epileptiform discharges. .
In vivo: So far, no study in vivo has been conducted.
Clinical trial: So far, no clinical study has been conducted.
 Waldmeier PC, Wicki P, Feldtrauer JJ, Mickel SJ, Bittiger H, Baumann PA. GABA and glutamate release affected by GABAB receptor antagonists with similar potency: no evidence for pharmacologically different presynaptic receptors. Br J Pharmacol. 1994 Dec;113(4):1515-21.
 Cunningham MD, Enna SJ. Evidence for pharmacologically distinct GABAB receptors associated with cAMP production in rat brain. Brain Res. 1996 May 13;720(1-2):220-4.
 Deisz RA. The GABA(B) receptor antagonist CGP 55845A reduces presynaptic GABA(B) actions in neocortical neurons of the rat in vitro. Neuroscience. 1999;93(4):1241-9.
 Zhang M, Buttigieg J, Nurse CA. Neurotransmitter mechanisms mediating low-glucose signalling in cocultures and fresh tissue slices of rat carotid body. J Physiol. 2007 Feb 1;578(Pt 3):735-50. Epub 2006 Nov 23.
 Salah A, Perkins KL. Effects of subtype-selective group I mGluR antagonists on synchronous activity induced by 4-aminopyridine/CGP 55845 in adult guinea pig hippocampal slices. Neuropharmacology. 2008 Jul;55(1):47-54. doi: 10.1016/j.neuropharm.2008.04.010. Epub 2008 Apr 23.
|Physical Appearance||White solid|
|Storage||Store at RT|
|Solubility||<43.87mg/ml in DMSO|
|Chemical Name||benzyl((S)-3-(((S)-1-(3,4-dichlorophenyl)ethyl)amino)-2-hydroxypropyl)phosphinic acid hydrochloride|
|Canonical SMILES||C[[email protected]@](NC[[email protected]@](O)([H])CP(CC1=CC=CC=C1)(O)=O)([H])C2=CC(Cl)=C(Cl)C=C2.Cl|
|Shipping Condition||Evaluation sample solution : ship with blue ice.All other available size: ship with RT , or blue ice upon request|
|General tips||For obtaining a higher solubility , please warm the tube at 37 ℃ and shake it in the ultrasonic bath for a while.Stock solution can be stored below -20℃ for several months.|